A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 9, 2012, Pages 1146-1154

  Li, Yunfei ^a   Yang, Feifei ^a   Chen, Wei ^a   Liu, Jiaoyang ^b   Huang, Wei ^a   Jin, Mingji ^a   Gao, Zhonggao ^a,c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b YANBIAN UNIVERSITY   (China)

^c Department of Electrical and Computer Engineering   (United States)

Author keywords

Anti metastasis; Docetaxel; Drug loading efficiency; Micelle; Poly(D,L lactide) b polyethylene glycol methoxy; Reconstitution

Indexed keywords

DOCETAXEL; DUOPAFEI; GLUCOSE; MACROGOL; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; GUINEA PIG; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS INHIBITION; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; GUINEA PIGS; HEMOLYSIS; LACTIC ACID; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICELLES; NEOPLASM METASTASIS; POLYETHYLENE GLYCOLS; POLYMERS; RATS; TAXOIDS;

EID: 84865970288     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c12-00323     Document Type: Article

References (33)

1. Baker J., Ajani J., Scotté F., Winther D., Martin M., Aapro M. S., von Minckwitz G., Eur. J. Oncol. Nurs., 13, 49-59 (2009).
2. Kintzel P. E., Michaud L. B., Lange M. K., Pharmacotherapy, 26, 853-867 (2006).
3. Persohn E., Canta A., Schoepfer S., Traebert M., Mueller L., Gilardini A., Galbiati S., Nicolini G., Scuteri A., Lanzani F., Giussani G., Cavaletti G., Eur. J. Cancer, 41, 1460-1466 (2005).
4. Tong R., Cheng J., Pol. Rev., 47, 345-381 (2007).
5. Gu F., Zhang L., Teply B. A., Mann N., Wang A., Radovic-Moreno A. F., Langer R., Farokhzad O. C., Proc. Natl. Acad. Sci. U.S.A., 105, 2586-2591 (2008).
6. Zhang L., Radovic-Moreno A. F., Alexis F., Gu F. X., Basto P. A., Bagalkot V., Jon S., Langer R. S., Farokhzad O. C., ChemMedChem, 2, 1268-1271 (2007).
7. Farokhzad O. C., Cheng J., Teply B. A., Sherifi I., Jon S., Kantoff P. W., Richie J. P., Langer R., Proc. Natl. Acad. Sci. U.S.A., 103, 6315-6320 (2006).
8. Cheng J., Teply B. A., Sherifi I., Sung J., Luther G., Gu F. X., Levy-Nissenbaum E., Radovic-Moreno A. F., Langer R., Farokhzad O. C., Biomaterials, 28, 869-876 (2007).
9. Kim T. Y., Kim D. W., Chung J. Y., Shin S. G., Kim S. C., Heo D. S., Kim N. K., Bang Y. J., Clin. Cancer Res., 10, 3708-3716 (2004).
10. Lee S. W., Yun M. H., Jeong S. W., In C. H., Kim J. Y., Seo M. H., Pai C. M., Kim S. O., J. Controlled Release, 155, 262-271 (2011).
11. Mu C. F., Balakrishnan P., Cui F. D., Yin Y. M., Lee Y. B., Choi H. G., Yong C. S., Chung S. J., Shim C. K., Kim D. D., Biomaterials, 31, 2371-2379 (2010).
12. Hamblett K. J., Senter P. D., Chace D. F., Sun M. M., Lenox J., Cerveny C. G., Kissler K. M., Bernhardt S. X., Kopcha A. K., Zabinski R. F., Meyer D. L., Francisco J. A., Clin. Cancer Res., 10, 7063-7070 (2004).
13. Konan Y. N., Gurny R., Allémann E., Int. J. Pharm., 233, 239-252 (2002).
14. Yi Y., Yoon H. J., Kim B. O., Shim M., Kim S. O., Hwang S. J., Seo M. H., J. Controlled Release, 117, 59-67 (2007).
15. Gaucher G., Dufresne M. H., Sant V. P., Kang N., Maysinger D., Leroux J. C., J. Controlled Release, 109, 169-188 (2005).
16. Yang M., Ding Y., Zhang L., Qian X., Jiang X., Liu B., J. Biomed. Mater. Res. A, 81, 847-857 (2007).
17. Danhier F., Lecouturier N., Vroman B., Jérôme C., Marchand-Brynaert J., Feron O., Préat V., J. Controlled Release, 133, 11-17 (2009).
18. Pulaski B.A., Ostrand-Rosenberg S., Current Protocols in Immunology, Supplement 39, chat. 20.2.1-20.2.16 (2000).
19. Driscoll D. F., Etzler F., Barber T. A., Nehne J., Niemann W., Bistrian B. R., Int. J. Pharm., 219, 21-37 (2001).
20. Tang N., Du G., Wang N., Liu C., Hang H., Liang W., J. Natl. Cancer Inst., 99, 1004-1015 (2007).
21. Zhang X., Jackson J. K., Burt H. M., Int. J. Pharm., 132, 195-206 (1996).
22. Liggins R. T., Burt H. M., Adv. Drug Deliv. Rev., 54, 191-202 (2002).
23. Harris T. J., Green J. J., Fung P. W., Langer R., Anderson D. G., Bhatia S. N., Biomaterials, 31, 998-1006 (2010).
24. Musumeci T., Vicari L., Ventura C. A., Gulisano M., Pignatello R., Puglisi G., J. Nanosci. Nanotechnol., 6, 3118-3125 (2006).
25. Mu L., Teo M. M., Ning H. Z., Tan C. S., Feng S. S., J. Controlled Release, 103, 565-575 (2005).
26. Xiao L., Xiong X., Sun X., Zhu Y., Yang H., Chen H., Gan L., Xu H., Yang X., Biomaterials, 32, 5148-5157 (2011).
27. Aslakson C. J., Miller F. R., Cancer Res., 52, 1399-1405 (1992).
28. Pulaski B. A., Ostrand-Rosenberg S., Cancer Res., 58, 1486-1493 (1998).
29. Pollard J. W., Nat. Rev. Cancer, 4, 71-78 (2004).
30. Pollard J. W., J. Leukoc. Biol., 84, 623-630 (2008).
31. Joyce J. A., Pollard J. W., Nat. Rev. Cancer, 9, 239-252 (2009).
32. Hanahan D., Weinberg R. A., Cell, 144, 646-674 (2011).
33. Zhang X., Burt H. M., Von Hoff D., Dexter D., Mangold G., Degen D., Oktaba A. M., Hunter W. L., Cancer Chemother. Pharmacol., 40, 81-86 (1997).